![Michael Mischke-Reeds](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Michael Mischke-Reeds first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Mischke-Reeds via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
C.R. BARD | Medical Specialties | General Counsel | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Terremoto Biosciences, Inc.
![]() Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Septerna, Inc.
![]() Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
Asher Biotherapeutics, Inc.
![]() Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Regeneration NewCo, Inc.
![]() Regeneration NewCo, Inc. Financial ConglomeratesFinance Regeneration NewCo, Inc. operates as a development stage company. The company is headquartered in South San Francisco, CA. | Financial Conglomerates | Director/Board Member | |
Maze Therapeutics, Inc.
![]() Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Ambys Medicines, Inc.
![]() Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
Delinea, Inc. (United States)
![]() Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Biotechnology | Chairman | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Harvard Medical School | College/University | Graduate Degree | |
Harvard College | College/University | Undergraduate Degree | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rapport Therapeutics, Inc.
![]() Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Tumbleweed Communications Corp.
![]() Tumbleweed Communications Corp. Packaged SoftwareTechnology Services Tumbleweed Communications Corp. provides security solutions for email protection, file transfers, and identity validation that allow organizations to safely conduct business over the Internet. The firm's products include secure transactions with identity validation, email, and file transfer. The company is headquartered in Redwood City, CA. | Packaged Software | Corporate Officer/Principal | |
Cello Health BioConsulting Inc.
![]() Cello Health BioConsulting Inc. Miscellaneous Commercial ServicesCommercial Services Cello Health BioConsulting Inc. operates as a business development strategy consulting firm. It offers opportunity assessments, portfolio and platform strategy, and identification and evaluation of In-licensing and acquisition opportunities. The company was founded by Ed Saltzman and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Founder | |
Yale University | College/University | Undergraduate Degree | |
PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Lumanity, Inc. (United States)
![]() Lumanity, Inc. (United States) Data Processing ServicesTechnology Services Part of Lumanity, Inc., the company is a data analytics firm based in Bethesda, MD. The company specializes in transforming data into real-world insights and evidence to power successful commercialization and empower stakeholders to take timely and decisive action. Jon Williams has been the CEO of the company since 2022. | Data Processing Services | Corporate Officer/Principal | |
Israel Biotech Fund
![]() Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
Vidac Pharma Ltd.
![]() Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
New York University | College/University | Undergraduate Degree | |
SANA AB | Biotechnology | Director/Board Member | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Human Resources Officer | |
ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
Washington University in St. Louis | College/University | Graduate Degree | |
Dartmouth College | College/University | Undergraduate Degree | |
Tessera Technologies LLC
![]() Tessera Technologies LLC SemiconductorsElectronic Technology Tessera Technologies, Inc. develops and licenses innovative semiconductor, interconnect and imaging technologies. The company offers mobile computing and communications, memory and data storage and 3-D Integrated Circuit technologies. Tessera Technologies was founded in 1990 and is headquartered in San Jose, CA. | Semiconductors | Human Resources Officer | |
DIALOGIC INC | Computer Peripherals | General Counsel | |
SHATTUCK LABS, INC. | Biotechnology | Director/Board Member | |
Tourmaline Bio, Inc.
![]() Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Chairman | |
JOHNSON CONTROLS INTERNATIONAL PLC | Industrial Machinery | General Counsel | |
National Association of Corporate Directors (New Jersey) | Director/Board Member | ||
Crowell & Moring LLP
![]() Crowell & Moring LLP Miscellaneous Commercial ServicesCommercial Services Crowell & Moring LLP provides legal services. It offers litigation and arbitration, regulatory, and transactional matters. The firm serves the aerospace and defense, automotive and trucking, aviation, chemicals, education, energy, financial institutions, and government contracting industries. The company was founded in 1979 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ENPRO INC. | Industrial Machinery | Director/Board Member | |
CORNERSTONE BUILDING BRANDS, INC. | Building Products | Director/Board Member | |
Dun & Bradstreet Ltd.
![]() Dun & Bradstreet Ltd. Data Processing ServicesTechnology Services Part of Dun & Bradstreet Holdings, Inc., Dun & Bradstreet Ltd. is a British company that provides online business information. The company is based in Marlow, UK. The company was founded in 1841 by Lewis Tappan. | Data Processing Services | Director/Board Member | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
Cornell Law School | College/University | Graduate Degree | |
DUN & BRADSTREET CORP | Data Processing Services | Director/Board Member | |
MONSANTO | Wholesale Distributors | General Counsel |
Statistics
International
United States | 43 |
Israel | 3 |
United Kingdom | 3 |
Denmark | 2 |
Ireland | 2 |
Sectoral
Health Technology | 19 |
Commercial Services | 9 |
Consumer Services | 9 |
Technology Services | 5 |
Finance | 4 |
Operational
Director/Board Member | 30 |
Independent Dir/Board Member | 14 |
Corporate Officer/Principal | 11 |
Chairman | 9 |
General Counsel | 8 |
Most connected contacts
Insiders | |
---|---|
Judith Reinsdorf | 18 |
Clay Siegall | 18 |
Jeffrey Tong | 16 |
Eric C. Schlezinger | 10 |
Edward Saltzman | 7 |
Paul Silva | 5 |
Paula O’Connor | 4 |
Silinda Neou | 1 |
- Stock Market
- Insiders
- Michael Mischke-Reeds
- Company connections